Identification of High Risk People for Colorectal Cancer and Evaluation of a Specific Surveillance System
NCT ID: NCT02931825
Last Updated: 2019-05-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
7101 participants
INTERVENTIONAL
2017-05-23
2019-05-23
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The purpose of this project is to to offer and evaluate the feasibility and the effectiveness of a specific surveillance system for high risk people for colorectal cancer
The project will be divided into 2 phases:
Objectives of the first phase:
* Identify high risk people for colorectal cancer in the department of Indre-et-Loire,
* Fill in as completely as possible their colonoscopic history in the past 5 years,
* Estimate the proportion of high risk people for colorectal cancer in the target population for colorectal cancer screening in Indre-et-Loire (Men and women aged from 50 to 74 years).
Objective of the second phase:
Compare the performed colonoscopy rate of high risk people for colorectal cancer without notion of colonoscopy in the past 58 months following or not (control group) the sending of a letter reminding the importance of compliance with colonoscopy.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of EDUcation Strategy on Patients With COLorectal CANCER or Advanced Adenoma in the Detection of Colorectal Cancer of Their First-degree Relatives
NCT03084133
A Program for Improved Family Screening for Colorectal Cancer
NCT03620877
General Practitioners and Participation Rate in ColoRectal Cancer Screening
NCT04492215
Does the Recall by the General Practitioner Improve Patients' Participation in Colorectal Cancer Screening?
NCT01279330
Shared Decision-Making for Colorectal Cancer Screening
NCT00251862
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SCREENING
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Reminder letter
A letter is sent for remind the importance of compliance with colonoscopy AND to encourage people to to consult their general practitioner or gastroenterologist (if they haven't done their follow-up in time).
Reminder letter
The letter will consist in several parts:
* Reminder of : -the need of individual follow-up for high risk people for colorectal cancer AND - the general recommendations (one colonoscopy every 5 years)
* Recommendation to consult their general practitioner or gastroenterologist if they haven't done their follow up
* Request information if they've done their follow-up or if we have incorrect information
* Indication that the letter is sent as part of a surveillance program specific for high risk people for colorectal Cancer
Control
No intervention (what is done currently)
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Reminder letter
The letter will consist in several parts:
* Reminder of : -the need of individual follow-up for high risk people for colorectal cancer AND - the general recommendations (one colonoscopy every 5 years)
* Recommendation to consult their general practitioner or gastroenterologist if they haven't done their follow up
* Request information if they've done their follow-up or if we have incorrect information
* Indication that the letter is sent as part of a surveillance program specific for high risk people for colorectal Cancer
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* with increased risk for colorectal cancer
* who did not perform a colonoscopy in the past 58 months
Exclusion Criteria
50 Years
74 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Tours
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Somany SENGCHANH, Dr
Role: PRINCIPAL_INVESTIGATOR
Centre de Coordination des Dépistages des Cancers CHRU de Tours
Ken HAGUENOER, Dr
Role: PRINCIPAL_INVESTIGATOR
Centre de Coordination des Dépistages des Cancers
Julie Boyard
Role: PRINCIPAL_INVESTIGATOR
Centre de Coordination des Dépistages des Cancers
Thierry Lecomte, Pr
Role: STUDY_CHAIR
CHRU de Tours, Service Hépato- gastroentérologie
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UH Tours
Tours, Indre-et-Loire, France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2015-A01607-42
Identifier Type: OTHER
Identifier Source: secondary_id
INCa15-SS/ISIRECC
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.